Biome Australia rises on patent application for new probiotic strain
** Shares of Biome Australia BIO.AX rise as much as 1.5% to A$0.33, on track to log their best session since April 20 ** Biotherapeutics maker files patent application for its proprietary next-generation probiotic strain ** Marks co's entry into intellectual property development and innovation-driven growth, BIO says ** YTD, stock down 22% (Reporting by Anjali Singh in Bengaluru) ((anjali.singh2@thomsonreuters.com; ))
Recent news on Biome Australia
See all newsBiome Australia soars on signing Australian manufacturing deal
Brief: Biome Australia Says Probiotical Exclusive Supply Agreement Extended
Brief: Biome Australia Says Co Continues To Expect FY26 To Be Profitable
Biome Australia rises on patent application for new probiotic strain
Brief: Biome Australia Files Patent Application For Probiotic Strain BMB18